I am the Cranial Osteopathic Physician that attended the August 2014 THOR Training in Boston and spoke with you quite a bit and my husband was the Naturopathic Physician there that day.
We now own 2 Thor Laser Lx2 Control Units with the 810nm infrared cluster probe and an LED probe. We have been using LLLT since September 2014 and we have had very remarkable results. Here are 2 case studies I would like to share.
• The first case was a woman in her early 60’s that came into my office on crutches in excruciating pain. She was crying out in pain so much that I sent her husband to the Pharmacy to pick up a prescription for Narcotic, which she took in my office while I was treating her with Osteopathic Manipulation.
It was a confirmed Herniated Nucleus Propulsus ( it’s called an intervertebral disc herniation by your treatment protocol). I treated her for 5 consecutive days (with the first IVD Herniation protocol) and on the Monday after these 5 treatments she was able to walk without assistance and was very close to being pain free.
LumiThera® Inc., a clinical stage medical device company focused on delivering non-invasive photobiomodulation (PBM) therapies for ocular disorders and disease, today announced it has been awarded the prestigious “MOST INNOVATIVE AND PROMISING MEDTECH & E-HEALTH COMPANY” during Biovision 2017 in Lyon, France.
This is great news for patients suffering from dry AMD who have no other treatment alternatives!
Zhang et al showed that whole body 810nm laser 100mW/cm2, 30J/cm2 cures acute thrombocytopenia in mice.
Thrombocytopenia is a common hematologic disorder that is managed primarily by platelet transfusions. They showed that noninvasive whole-body illumination cures acute thrombocytopenia triggered by g-irradiation within 2 weeks in mice, as opposed to a 5-week recovery time required in controls.
The low-level laser (LLL) also greatly accelerated platelet regeneration in the presence of anti-CD41 antibody that binds and depletes platelets, and prevented a severe drop in platelet count caused by a common chemo-therapeutic drug.
They conclude: this safe, drug-free, donor-independent modality represents a paradigm shift in the prophylaxis and treatment of thrombocytopenia.
Meagan is a National Level Weightlifter who competes frequently. See her story and experience below after sessions on the NovoTHOR whole-body light pod. PR stands for Personal Record.
Muscle Snatch Triple off a riser: PR working weight at 42 kg… Up 5 kilos from last week where I could only hit 37kg for working weight.
My 3/6 front squat/back squat combo I added 3 kilos from the previous Thursday- which is the most working I’ve ever done for this exercise at 91kg.
THEN I went on to do several reps of cleans and hit a 95kg Clean PR (9 kilos more than I did last week- heaviest clean I hit last week was 86kg.) This was halfway through my workout after doing a total of 117 reps. In Weightlifting a lot of volume can make your body feel tired & wrecked, so there was no explanation for why I was able to hit a PR on this exercise when my legs were fried.
Saturday 3/19: I hit a 3 kilo PR on my Power Clean & Jerk at 83kg
I added 2 kilos to my snatch triples from the blocks (59kg) from last week where I could only do 57kg.
I also did the most working weight I’ve ever done for Clean & Jerk Doubles at 83kg.
Sumo Deadlift triple: 127kg PR (up 5 kilos from last Monday 3/14 I only could hit 122kg for 3)
Snatch Deadlift 5 rep: PR working weight for 5 at 91kg (2 kilos more than last Monday.)
Push Press+Push Jerk + Split Jerk Complex: 75kg (up 2kg from last Monday’s workout)
This part of my training cycle has been very strength intensive, so for me to even be coming close to hitting PRs is a huge deal. My body should be more fatigued and worn down from the strength work, but I actually feel recovered and fresh.
130 new LLLT papers for you including a systematic review on shoulder tendinopathies, a lovely article review in an orthopaedics journal by Howard Cotler, four systematic reviews on orthodontic tooth movement, a trial showing LEDs improve sperm motility, another systematic review on oral mucositis and much more.
As reported here in 2013 there are no licensed drugs for non-specific neck pain because “there isn’t much specific research that shows drugs help neck pain”. For LLLT/PBM however, there are at least 16 (mostly positive) RCTs and a positive systematic review published in The Lancet. Despite this unequivocal evidence, the 2014 revised patient advice leaflet from the BMJ fails to mention LLLT/PBM but states “your doctor may recommend one or more of the following” and goes on to list pain killers, NSAIDs, antidepressants and muscle relaxants”.
This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).
The VA, Boston University and Harvard Medical School published the results of a Transcranial LLLT (LED) pilot study on mild Traumatic Brain Injury (TBI). Incredibly; TBI is a leading cause of death and disability among children and young adults in the United States. Each year an estimated 1.5 million Americans sustain a TBI, 50,000 people die as a consequence, 230,000 are hospitalized and an estimated 5.3 million currently live with a permanent TBI-related disability (because there is no cure). This study showed significant improvement in Executive Function, Verbal Learning, Long Delay Free Recall and fewer post-traumatic stress disorder (PTSD) symptoms. Participants and family reported better ability to perform social, interpersonal, and occupational functions. This was a small pilot study on just eleven patients with chronic mTBI, there was no placebo control group so further studies are necessary to truly establish the effect size.
The paper “High-intensity versus low-level laser therapy in the treatment of patients with knee osteoarthritis: a randomized controlled trial” Kheshie et al 2014 pitches the 3B BTL laser against the HIRO class IV “High intensity” laser. The results appear to show that the HIRO class IV “High intensity laser” was more effective than the “Low Level Laser”. HOWEVER, the HIRO class IV “High intensity” laser was delivered over a large area (not adequately defined but approx 100cm2 by my estimation) so the intensity was actually very low (about 13mW/cm2 which is less than most LED systems), and the 3B BTL “Low Level Laser” was actually very high (4 x 200mW small, high intensity beams) and were held stationary on the patella for over half an hour, YES, HALF AN HOUR IN ONE SPOT! This is insane.
This paper leads people to think that the class IV Hiro laser was more effective because it was higher intensity when in fact the beam distribution meant the average intensity distribution was low (13mW/cm2). The 3B laser was not so effective because it was held stationary such that it would cause an overdose. If the 3B laser treatment had been delivered in using same scanning technique as the class IV then they would likely have achieved the same result. (I am not a fan of scanning because you can never be sure how much energy you have delivered to an area, better to use a low intensity device and hold it still in my view).
This paper misdirects the reader towards favouring class IV lasers rather than 3b or LED by misinforming the reader.
TV, radio and newspapers all over the world got very excited last week reporting that “laser regenerates teeth” following a Harvard study. The study showed that LLLT stimulates the stem cells resident in the tooth pulp to form dentin (for details click below). This is the highest profile announcement for any LLLT paper ever and will add significant awareness and credibility for everyone in the field. Congratulations and huge thanks to the author Dr Praveen Arany B.D.S., M.D.S., M.M.Sc., Ph.D. who is now a Clinical Investigator at NIH.
The title of last months PMLS editorial was Low Level Laser Therapy (LLLT) and World Association for Laser Therapy (WALT) Dosage Recommendations. Written by the Scientific Secretary Prof. Jan Bjordal. He describes how far we have come and the importance of the WALT dosage recommendations. No abstract is available for editorials so I have prepared one for you below. Continue reading →
A paper titled ”The Effectiveness of Therapeutic Class IV (10 W) Laser Treatment for Epicondylitis” [ref] showed that 10 Watt Class IV laser (mixed 8W 970nm, 2W 810) was successful in reducing pain and improving function in an RCT with 15 patients, and that there was good statistical significance at 6 months following a course of 6 treatments.
The claim by class IV laser manufacturers is that class IV lasers are better (faster, deeper and more effective) than Class 3b and LED systems. Conversely the 3B laser and LED manufacturers argue that less power density is more effective because delivering energy too quickly can overdose tissues and class IV lasers might burn the skin.
Throughout this paper there are marketing messages claiming the advantages of shorter treatment times than low power LLLT systems and of course the title shouts “10 Watt Class IV laser” just in case the reader is in any doubt that more power is what you need.
Regular readers of this column know my obsession with irradiation parameters, particularly dose rate effects (W/cm2) and will not be surprised to learn that I deconstruced the irradiation parameters used in this trial . Surprise, surprise they were the same low irradiance levels typically used by 3B lasers and LED systems, if not less and the treatment time was longer too.
Yes, it was a 10 Watt laser and yes, 3,000 joules was delivered, however it had a large beam area and treatment was delivered over (45cm2) in a “painting fashion”. The fluence (dose) was 6.6 Joules/cm2 and the power density was a tiny 22mW/cm2, consequently treatment time was a hefty 5 mins.
The average irradiance was not disclosed in the paper and the reader is directed to think that more power is quicker.
P.S. research trials with 3B lasers are typically 30 seconds to 3 mins and our recommended treatment is 1 min with a large LED cluster to the lateral epicondyle and 30 seconds for any related trigger points.
David Sengeh has been developing powered limbs at MIT for amputees (like the bionic man). Where the powered limb attaches to the body (the stump of the original leg) it gets very sore. David has been using our standard THOR products to heal the stump and reduce pain. It works very well, though it takes a lot of time to treat the whole area. I am in Boston now to help David start clinical trials with a new device we designed that will treat the whole stump. The amputee puts the the leg stump into the LED treatment cylinder and gets a complete treatment in just one minute :-)
Available only to people who have attended a THOR training course in the last 3 years. All treatments are based on our four step method which includes treatment of the injury, trigger points, lymphatics and nerve roots.
Take a look to see how it works and let us know what you think.
“I started using NovoTHOR after months of knee irritation left me unable to squat. I also injured my neck and a Cat Scan indicated that my chronic neck pain was due to a slightly herniated disk in my cervical spine. For the next month, I started noticing that the excruciating pain I felt on a day to day basis that hindered me from doing certain movements in CrossFit, started declining the more I did NovoTHOR. Not only was I noticing a decrease in pain, but I noticed an overall improvement in my recovery from workouts, and I was starting to receive a deeper night’s sleep. Just about 6 weeks after starting NovoTHOR I hit a 10# PR on my Clean and Jerk at 315#, a number that I thought was untouchable due to my neck and knee pain. I’m now able to squat and do many other movements pain-free, just in time for the 2017 CrossFit Open.” – Tim Payne
“In 2012 I underwent shoulder surgery. When I returned to CrossFit, my shoulder was never 100 percent. I battled with pain on and off, while my performance slowly dropped. I sought NovoTHOR as a last resort before I decided if I wanted to undergo surgery again. Not only was I able to compete without restrictions within the first few weeks, but I achieved massive personal records on movements that were hindered by my shoulder pain. I added 7lbs to my snatch and 10lbs to my clean after years of 2-3lbs increases. NovoTHOR has made it possible for me to follow my passion of competing pain-free while reaping the benefits of increased performance.” — Jake Wade
“Really enjoyed the training day – extremely informative and James Carroll is an excellent and extremely knowledgeable presenter – I will definitely come on this again and bring all the staff as well !!”
John Rose B.Sc (Hons) Optometry & Visual Sciences
John Rose Eyecare
This is an extraordinary lecture. It is the story of how LLLT / Photobiomodulation was discovered, and because of the context in which it occurred you might also find it very moving, so get some tissues. It is an hour and 10 minutes long so get comfortable, maybe get some popcorn and a drink too. I will paste the email that Andrew Mester wrote into the comments section below.
Here is the email from Andrew Mester :
I had the privilege to give a keynote presentation at the most recent NAALT (North American Association of PhotobiomoduLation Therapy) meeting in February 5, 2017 in Coronado Island, San Diego. The title of paper was: “Invention of Laser Biostimulation”. My lecture is in Youtube now.
Photo-medicine is an exciting new field in both scientific and clinical research all over the world and most recently in the USA. I learned in this interesting meeting that low intensity laser and LED light may stimulate, heal and regenerate neural tissue. Possible treatments are under investigation regarding traumatic events (stroke, traumatic brain injury and global ischemia), degenerative diseases (dementia, Alzheimer and Parkinson’s disease) and psychiatric disorders (PTSD, depression and anxiety). Most American studies are sponsored by the NIH (Michael Hamblin, PhD, Mass General Hospital) and by the VA (Margaret Naeser, PhD at Boston Jamaica Plain VA Hospital).
My association to this field is that my Father, Endre Mester, MD published first biostimulatory effect of the low power laser in 1967. My father, myself and my brother, Adam Mester, MD have published all the basic both research and clinical studies in the literature. We described the stimulatory effect primarily in wound healing and also the systemic effect of laser irradiation which is used now in all of the above mentioned research protocols.
My father is called in the literature the “Father of Photobiomodulation”.
The NAALT society established an Award named after my father: “Professor Endre Mester Award who made the seminal observation on the therapeutic benefits of low dose laser treatments”. The award recognizes a clinician or researcher who has made significant contributions to our understanding of light-biological tissue interactions and its therapeutic benefits, specifically in the area of Photobiomodulation Therapy. I was asked to present this award to Michael Hamblin, PhD from Massachusetts General Hospital, Harvard Medical School because of his lifetime achievements in Photobiomodulation.
“I found the training course on the Thor Laser very informative and thorough. James is very dynamic and gave enough information for the time frame of the day. I am seriously contemplating purchasing this breakthrough piece of equipment. I feel that it should be part of any musculoskeletal treatment plan.”
Anna Grazia Pietrolungo